Table 2. AR CAG and GGC and PSA (G/A) frequency distribution and association with AR (A1675T) mutation in African Americans and Caucasian Americans with familial prostate cancers.
Characteristics | African American | Caucasians |
---|---|---|
No. of high-risk families | 15 | 15 |
No. of PCa-affected males1 | 37 | 30 |
PSA allele frequency2 | ||
A | 0.484 | 0.548 |
G | 0.516 | 0.452 |
AR (A1675T) allele frequency3 | ||
A | 0.958 | N/A |
T | 0.042 | N/A |
PSA genotype linkage4 with: | ||
AR (A1675T) mutation status | 1.0 | N/A |
CAG repeats (≤ 22) | 0.857 | 1.0 |
GGC repeats (≤ 16) | 1.0 | 1.0 |
AR mutation linkage5 with: | ||
CAG repeats (≤ 22) | 1.0 | N/A |
GGC repeats (≤ 16) | 0.20 | N/A |
Abbreviations: PCa, prostate cancer; AR, androgen receptor; PSA, prostate-specific antigen; N/A, not applicable.
PCa-affected males are brothers within a nuclear family
Estimated with Mendel v9.0, autosomal
Estimated with Mendel v9.0, X-linked
Exact P-value using Reconstruction-combination transmission disequilibrium test procedure assuming full sibships
Exact P-values using X-linked reconstruction combination-transmission/disequilibrium Test procedure assuming full sibships.